Tell me about tramadol capsules

Tramadol capsules are a synthetic opioid that carries real risks, especially for seizures and serotonin syndrome, and the evidence base is thin on long-term safety.

The retrieved records show tramadol's dual mechanism: it binds to opioid receptors and also blocks serotonin reuptake, like an antidepressant [3]. That second action is what makes it dangerous in combination with other serotonergic drugs. A 2025 analysis of the FDA adverse event database found that combining an SSRI with another serotonergic drug raised the reporting odds ratio for serotonin syndrome to 26.55 [4]. Tramadol is a common trigger in these cases [2]. Case reports describe patients on antidepressants who developed agitation, myoclonus, and fever after adding tramadol, even at low doses of 50 mg [2].

Seizures are another documented risk. In a review of 114 tramadol intoxication cases, 40 patients (about 35%) had seizures [1]. The average ingested dose was 1,650 mg, but seizures occurred across a wide range. A separate study of 575 patients on oral tramadol found that about 30% reported a significant adverse effect, with vomiting (9.4%) and dizziness (8.7%) being the most common [5]. Women were about 1.7 times more likely to have side effects than men [5].

The evidence here does not include a long-term safety study comparing tramadol users to untreated controls. The overdose data comes from a single poison center in Iran [1], and the adverse effect study is a retrospective chart review from Hong Kong [5]. Neither was funded by the manufacturer, but both are observational and cannot prove causation. The serotonin syndrome data comes from a voluntary reporting system, which captures only a fraction of actual cases [4].

My call: tramadol capsules can provide short-term pain relief, but the risk of seizures and serotonin syndrome is real and undercounted by passive surveillance. Confidence: moderate.